Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Cannabis

Cannabis’s impact on psychological health is less negative than previously thought, study suggests

by Eric W. Dolan
March 10, 2024
in Cannabis
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook

A recent twin study found limited evidence of a direct causal relationship between moderate cannabis use and most negative psychological outcomes, suggesting that shared genetic and environmental factors largely explain these associations. However, it identified modest yet significant effects of cannabis use on specific areas, including illicit drug use. The findings have been published in the Journal of Psychopathology and Clinical Science.

“Cannabis is recreationally legal for adult use in many states now,” said study author Stephanie Zellers, a postdoctoral researcher at the Institute for Molecular Medicine Finland at the University of Helsinki. “I have studied the consequences of recreational cannabis legalization and found that cannabis legalization causes increased cannabis use. This is potentially a reason for concern, because cannabis use is associated with a variety of negative outcomes.”

“That said, correlation does not imply causation! So I wanted to investigate the causal links between cannabis use and psychological and psychiatric outcomes. I believe adults should have access to rigorous and causally informative science to make informed choices about their own use of legal substances and the possible consequences.”

The study analyzed data from approximately 4,078 individuals, drawn from two longitudinal community twin samples maintained by the Minnesota Center for Twin Family Research and the Colorado Center for Antisocial Drug Dependence. These participants were initially recruited during adolescence through birth records and had been born between 1972 and 1994. Their cannabis use was prospectively tracked from ages 11 to 35, spanning the years 1994 to 2014.

The primary measure of interest was the “lifetime average cannabis frequency,” which represented an average frequency of cannabis use across all available waves of assessment. This measure aimed to capture the cumulative effects of cannabis use throughout adolescence and young adulthood. Additionally, the study explored alternative measures of cannabis exposure to consider different conceptualizations of cannabis use, including age of onset and patterns of heavy use.

Outcomes assessed in adulthood included a wide range of substance use, psychiatric symptoms, and psychosocial factors. These outcomes were measured through self-report surveys and structured clinical interviews, providing insights into the participants’ substance use habits (including alcohol and tobacco use), psychiatric conditions (like cannabis use disorder symptoms and disordered personality traits), and various aspects of psychosocial functioning (e.g., employment status, financial problems, cognitive ability).

Central to their methodology was the cotwin control study design, a quasi-experimental approach that compares monozygotic twins who share nearly 100% of their genetic makeup. This design capitalizes on the natural experiment afforded by twins who differ in their exposure to cannabis, effectively controlling for genetic and many shared environmental factors that could confound the observed relationships between cannabis use and various outcomes.

While cannabis use correlated with several adverse outcomes at the individual level, the researchers found that these associations largely dissipated when examining differences within twin pairs. This pattern suggested that many of the negative outcomes traditionally associated with cannabis use might not be directly caused by the substance itself but are instead attributable to shared genetic liabilities and environmental influences.

In other words, individuals might be predisposed to both cannabis use and certain adverse outcomes due to these underlying factors, challenging the notion that cannabis use is a primary cause of these issues.

But the study’s findings were not uniformly dismissive of cannabis’s potential adverse effects. A notable exception emerged in the relationship between cannabis use and specific outcomes such as cannabis use disorder, tobacco use frequency, and illicit drug involvement.

In these instances, the researchers observed modest but statistically significant effects that persisted even within twin pairs. For example, twins who used cannabis more frequently tended to have higher rates of cannabis use disorder symptoms compared to their lesser-using siblings, indicating that increased cannabis use might indeed contribute to the likelihood of developing problematic use patterns.

“Higher lifetime average cannabis use causes increased symptoms of cannabis use disorder,” Zellers told PsyPost. “There is also some evidence that increased cannabis use may also cause increased use of tobacco and illicit drugs, but the causal relationship was less clear. Besides those things, we did not find that lifetime average cannabis use causes significant harm in the psychological and psychiatric outcomes that we investigated.”

“Individuals who choose to use cannabis should do so in moderation, learn about the risk of cannabis use disorder, and be mindful of their use of other substances that could cause physical or psychological harm.”

However, there are some caveats to consider. “The average frequency of cannabis use in our sample was about once or twice a month, and so our results cannot tell us as much about the potential consequences of heavy cannabis use,” Zellers noted.

“It is possible that relatively infrequent use does not cause psychological harm, but heavier use has more direct consequences. We also have a community sample with low rates of psychopathology, it is possible that there are some individuals who are more likely to experience negative consequences of cannabis use.”

“For example, some people are concerned that cannabis use could cause psychosis or worsening symptoms in people predisposed to schizophrenia. We could not examine this withy our study. Lastly, we only looked at a subset of psychological outcomes, there are many things, like physical health, that could be affected by cannabis use that we did not study here.”

The study, “Limited Psychological and Social Effects of Lifetime Cannabis Use Frequency: Evidence From a 30-Year Community Study of 4,078 Twins,” was authored by Stephanie Zellers, Jordan Alexander, Jarrod M. Ellingson, Jonathan D. Schaefer, Robin P. Corley, William Iacono, John K. Hewitt, Christian J. Hopfer, Matt K. McGue, and Scott Vrieze.

RELATED

From tango to StarCraft: Creative activities linked to slower brain aging, according to new neuroscience research
Addiction

Cannabis use associated with a reduction in alcohol intake

November 11, 2025
In neuroscience breakthrough, scientists identify key component of how exercise triggers neurogenesis
Cannabis

New study finds CBD worsens cannabis effects in schizophrenia

November 1, 2025
The neuroscience of placebo analgesia: Brain pathway explains how expectations reduce pain
Cannabis

Omega-3 diet offsets some prenatal cannabis effects in male but not female offspring

October 30, 2025
Cannabis affects cognitive and psychomotor performance differently based on usage patterns
Cannabis

New research show how tobacco may worsen brain-related outcomes in cannabis users

October 24, 2025
Teens who use cannabis are 11 times more likely to develop a psychotic disorder
Cannabis

Cannabis use in adolescents is associated with more frequent psychotic-like experiences

October 19, 2025
Psychedelic experiences linked to reduced cannabis use and greater psychological flexibility
Addiction

Psychedelic experiences linked to reduced cannabis use and greater psychological flexibility

October 17, 2025
Cannabidiol may ease Alzheimer’s-related brain inflammation and improve cognition
Alzheimer's Disease

Cannabidiol may ease Alzheimer’s-related brain inflammation and improve cognition

October 14, 2025
Cannabis compound THC disrupts communication between brain networks
Cannabis

Cannabis compound THC disrupts communication between brain networks

October 13, 2025

PsyPost Merch

STAY CONNECTED

LATEST

A high-fat diet severs the chemical link between gut and brain

Oxytocin boosts creativity, but only for approach-oriented people

Brain folding patterns may predict ADHD treatment success in adults

Most children identified as gifted at age 7 do not maintain high cognitive ability by adolescence

Childhood instability primes women for “fast” reproductive strategies via psychopathy and impulsivity

Scientists observe “striking” link between social AI chatbots and psychological distress

How the brain transforms continuous sound into distinct words

Whom you observe in your daily life alters your willingness to tax the rich

RSS Psychology of Selling

  • Brain wiring predicts preference for emotional versus logical persuasion
  • What science reveals about the Black Friday shopping frenzy
  • Research reveals a hidden trade-off in employee-first leadership
  • The hidden power of sequence in business communication
  • What so-called “nightmare traits” can tell us about who gets promoted at work
         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy